Dawnrays Pharmaceutical (Holdings) Limited
2348.HK News Today: Stay Updated with the Latest Dawnrays Pharmaceutical (Holdings) Limited News in Real Time
Find 2348.HK news now at Meyka AI. Stay informed with the latest Dawnrays Pharmaceutical (Holdings) Limited stocks updates, including price news, market analysis, and expert insights.
Gold Price Holds Near $4,590 After Slide as Iran War Fuels Inflation and Rate Uncertainty
The global Gold Price is holding steady near the $4,590 per ounce level after recent volatility in the market. The yellow metal has faced a sharp rise and correction phase, but it continues to attract attention from investors worldwide. We are seeing a complex mix of factors driving this movement. The ongoing Iran conflict, rising…
PKG Neutral Rating Maintained by UBS on April 29, 2026
UBS maintained Neutral rating on PKG, raising price target to $232 from $225. Stock trades at $222.59 with B+ grade.
OSE.PA stock surges 16% on FDA orphan drug designation for VEL-101
OSE.PA jumps 16.18% to €4.25 on FDA orphan drug designation for partner Veloxis’ VEL-101 heart transplant therapy.
SNDK Earnings Preview: Sandisk Reports April 30 Results
Sandisk (SNDK) earnings preview for April 30, 2026. EPS estimate $14.43, revenue $4.69B. Analyst consensus bullish with 29 buy ratings.
0470.HK WUXI Lead Earnings Miss: EPS Down 30.57%
WUXI Lead (0470.HK) missed Q1 2026 earnings with EPS of $0.2987 vs $0.4302 estimate, revenue $4.24B vs $5.31B expected.
6936.HK S.F. Holding Earnings Beat: EPS Tops Estimates
S.F. Holding (6936.HK) beat EPS estimates with $0.574 vs $0.552 expected. Revenue hit $85.18B. Meyka rates B+.
AMGN Earnings Preview: $4.73 EPS Expected April 30
Amgen earnings preview for April 30, 2026. Analysts expect $4.73 EPS and $8.58B revenue. Historical beat/miss analysis inside.
BHRB Director McLaughlin Buys 1,000 Shares April 28, 2026
Burke & Herbert director Shawn Patrick McLaughlin purchases 1,000 BHRB shares at $64.80 on April 28, 2026. Insider buying signal.
MRK Merck Earnings Preview April 30, 2026
Merck earnings preview: Analysts expect -$1.51 EPS and $15.85B revenue on April 30, 2026. Historical performance analysis.